- Report
- March 2021
- 99 Pages
Global
From €1327EUR$1,375USD£1,138GBP
€2654EUR$2,750USD£2,277GBP
- Report
- June 2022
- 58 Pages
Global
- Report
- October 2022
- 200 Pages
Global
From €2847EUR$2,950USD£2,442GBP
- Report
- August 2020
- 183 Pages
Global
From €3074EUR$3,185USD£2,637GBP
€4392EUR$4,550USD£3,767GBP
- Report
- November 2021
- 527 Pages
Global
From €3861EUR$4,000USD£3,312GBP
- Report
- November 2021
- 802 Pages
Global
From €4826EUR$5,000USD£4,140GBP
- Report
- September 2019
Asia Pacific
From €5183EUR$5,370USD£4,446GBP
- Report
- April 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Report
- April 2023
- 147 Pages
Global
From €5790EUR$5,999USD£4,967GBP
- Book
- November 2019
- 440 Pages
- Book
- November 2008
- 496 Pages
- Book
- April 2014
- 1384 Pages
- Book
- September 2023
- 640 Pages
Gene Silencing is a biotechnology process that involves the suppression of gene expression. It is used to study gene function, identify gene targets for drug discovery, and develop gene therapies. Gene silencing can be achieved through a variety of methods, including RNA interference (RNAi), antisense technology, and epigenetic modifications. RNAi is the most widely used gene silencing technique, as it is a highly specific and efficient method of gene suppression.
Gene silencing has become an important tool in the biotechnology industry, as it can be used to study gene function, identify gene targets for drug discovery, and develop gene therapies. It has also been used to develop new crop varieties with improved traits, such as disease resistance and increased yield.
Companies in the gene silencing market include Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Illumina, Inc., and New England Biolabs. Show Less Read more